These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7504374)

  • 1. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 3. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 5. [A seroprevalence study of the hepatitis C virus among multiply transfused patients].
    Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M
    Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.
    Mihaljević I; Feldbauer J; Delajlija M; Grgicević D
    Vox Sang; 1992; 63(3):236. PubMed ID: 1333138
    [No Abstract]   [Full Text] [Related]  

  • 7. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
    Bååth L; Widell A
    Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major.
    Lau YL; Chow CB; Lee AC; Ng KW; Lim WL; Chan CF; Lam SY; Li CK
    Bone Marrow Transplant; 1993; 12 Suppl 1():26-8. PubMed ID: 7690634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
    Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
    Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Cooleycare Group.
    Rebulla P; Mozzi F; Contino G; Locatelli E; Sirchia G
    Transfus Med; 1992 Mar; 2(1):69-70. PubMed ID: 1284983
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus antibodies in Sydney blood donors.
    Archer GT; Buring ML; Clark B; Ismay SL; Kenrick KG; Purusothaman K; Kaldor JM; Bolton WV; Wylie BR
    Med J Aust; 1992 Aug; 157(4):225-7. PubMed ID: 1279363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
    Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
    Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.